Yield10 Bioscience

Yield10 Bioscience Net Debt per Share

The Net Debt per Share of Yield10 Bioscience (YTENQ) as of Nov 3, 2026 is -16.09 USD. In the previous year, Net Debt per Share was -8.41 USD — a change of 91.38% (lower).

Net Debt per Share

-16.09USD

YoY

91.38%

Last updated:

Net Debt per Share of Yield10 Bioscience is 2019 -16.09 USD. Net Debt per Share of Yield10 Bioscience was 2018 -8.41 USD. It decreases by 91.38% lower compared to the previous year.

The Yield10 Bioscience Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2014
-28.99 USD
Jan 1, 2015
-17.83 USD
Jan 1, 2016
-10.58 USD
Jan 1, 2017
-21.01 USD
Jan 1, 2018
-8.41 USD
Jan 1, 2019
-16.09 USD
The Yield10 Bioscience Net Debt per Share history
YEARNet Debt per ShareYoY
-16.09USD+91.38%
-8.41USD-60.00%
-21.01USD+98.63%
-10.58USD-40.65%
-17.83USD-38.50%
-28.99USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Yield10 Bioscience Stock analysis

What does Yield10 Bioscience do? Yield10 Bioscience develops Camelina sativa as a platform crop for low carbon sustainable seed products, including Camelina oil for biofuel feedstock, Omega-3 oils for nutrition, and PHA Bioplastics for biodegradable packaging. The company uses its TraitFactory platform to discover genetic traits for agriculture and food industries, focusing on herbicide tolerance and disease resistance in Camelina germplasm. Its products target petroleum replacement markets, food and nutrition sectors, and animal feed markets, with development pipelines focused on improving Camelina varieties. The company's primary products are Camelina oil, Omega-3 oils, and PHA Bioplastics, sold to markets addressing petroleum replacement, nutrition, and sustainable packaging needs. Camelina sativa serves as the core crop for all seed product development, with TraitFactory enabling trait discovery for agricultural and food applications. The firm targets industrial buyers in biofuel, nutrition, and packaging industries seeking sustainable alternatives to petroleum-based products. Yield10 Bioscience's revenue streams come from the sale of Camelina-based products to companies in the biofuel, nutrition, and packaging sectors. The company focuses on developing high-value genetic traits through TraitFactory, which are integrated into Camelina varieties for large-scale production of seed products. Its development pipeline emphasizes traits like herbicide tolerance and disease resistance to enhance crop performance and market appeal. Yield10 Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Yield10 Bioscience stock

Net Debt per Share of Yield10 Bioscience is -16.09 USD in 2019.

Net Debt per Share of Yield10 Bioscience changed from -8.41 USD to -16.09 USD, representing a 91.38% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Yield10 Bioscience since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Yield10 Bioscience

All Key Metrics — Yield10 Bioscience